Patent Expiry
ACAD: NUPLAZID: recorded patent 10849891 expiry
August 27, 2038 · PIMAVANSERIN TARTRATE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- August 27, 2038
- Company
- ACADIA PHARMACEUTICALS INC (ACAD)
- Drug
- PIMAVANSERIN TARTRATE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
NUPLAZID: recorded patent 10849891 expiry
Orange Book application NDA210793, product 001, listed patent 10849891 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source